Literature DB >> 10716671

The human two domain trefoil protein, TFF2, is glycosylated in vivo in the stomach.

F E May1, J I Semple, J L Newton, B R Westley.   

Abstract

BACKGROUND: TFF2, a member of the trefoil factor family (TFF) of peptides, is a secreted protein of 106 amino acids that is expressed in mucous neck cells of the fundus and glands at the base of the antrum in normal human stomach. TFF2 is also detected at high concentrations around sites of ulceration. It is protective against mucosal damaging agents and stimulates cell motility. AIMS: To measure the expression of TFF2 in normal human stomach and its secretion into gastric juice.
METHODS: TFF2 cDNA was amplified by reverse transcription polymerase chain reaction from gastric mucosa and sequenced. Gastric juice or cytosol, prepared from gastric mucosa, was obtained from individuals with macroscopically normal stomachs. TFF2 concentrations were measured by quantitative western transfer analysis.
RESULTS: Sequencing of TFF2 cDNA revealed a single amino acid change from the published sequence. Significant amounts of 12 kDa TFF2 were detected in human gastric juice. Larger quantities of a protein of higher apparent molecular mass were also detected. This was shown to be N-glycosylated TFF2 using the endoglycosidase, peptide-N-Gycosidase F. The majority of TFF2 in normal gastric mucosa was also glycosylated.
CONCLUSIONS: Human TFF2 is glycosylated via an N-linkage, presumably on Asn(15) which forms part of the single consensus site for N-glycosylation in human TFF2. The glycosylation may be of functional significance. Future studies of human TFF2 should use antibodies raised against the correct amino acid sequence. Biological studies should be performed with recombinant protein of the correct sequence, and the biological consequences of glycosylation investigated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716671      PMCID: PMC1727891          DOI: 10.1136/gut.46.4.454

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Trefoil peptides: from structure to function.

Authors:  L Thim
Journal:  Cell Mol Life Sci       Date:  1997-12       Impact factor: 9.261

2.  Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration.

Authors:  R J Playford; T Marchbank; R Chinery; R Evison; M Pignatelli; R A Boulton; L Thim; A M Hanby
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

3.  Crystal structure of a disulfide-linked "trefoil" motif found in a large family of putative growth factors.

Authors:  A De; D G Brown; M A Gorman; M Carr; M R Sanderson; P S Freemont
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

4.  Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach.

Authors:  A M Hanby; R Poulsom; S Singh; G Elia; R E Jeffery; N A Wright
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

5.  Pancreatic spasmolytic polypeptide: first three-dimensional structure of a member of the mammalian trefoil family of peptides.

Authors:  M Gajhede; T N Petersen; A Henriksen; J F Petersen; Z Dauter; K S Wilson; L Thim
Journal:  Structure       Date:  1993-12-15       Impact factor: 5.006

6.  Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.

Authors:  A Dignass; K Lynch-Devaney; H Kindon; L Thim; D K Podolsky
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

7.  Oral trefoil peptides protect against ethanol- and indomethacin-induced gastric injury in rats.

Authors:  M W Babyatsky; M deBeaumont; L Thim; D K Podolsky
Journal:  Gastroenterology       Date:  1996-02       Impact factor: 22.682

8.  The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide.

Authors:  G Elia; R Chinery; A M Hanby; R Poulsom; N A Wright
Journal:  Histochem J       Date:  1994-08

9.  Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach.

Authors:  M R Alison; R Chinery; R Poulsom; P Ashwood; J M Longcroft; N A Wright
Journal:  J Pathol       Date:  1995-04       Impact factor: 7.996

10.  Solution structure of a trefoil-motif-containing cell growth factor, porcine spasmolytic protein.

Authors:  M D Carr; C J Bauer; M J Gradwell; J Feeney
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

View more
  11 in total

1.  Dramatic diurnal variation in the concentration of the human trefoil peptide TFF2 in gastric juice.

Authors:  J I Semple; J L Newton; B R Westley; F E May
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Trefoil factor family peptide 2 acts pro-proliferative and pro-apoptotic in the murine retina.

Authors:  Adnana N Paunel-Görgülü; Andreas G Franke; Friedrich P Paulsen; Nicole Dünker
Journal:  Histochem Cell Biol       Date:  2011-04-22       Impact factor: 4.304

3.  Human trefoil factor 2 is a lectin that binds α-GlcNAc-capped mucin glycans with antibiotic activity against Helicobacter pylori.

Authors:  Franz-Georg Hanisch; David Bonar; Nils Schloerer; Horst Schroten
Journal:  J Biol Chem       Date:  2014-08-14       Impact factor: 5.157

Review 4.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

5.  Activation of protease-activated receptor (PAR) 1 by frog trefoil factor (TFF) 2 and PAR4 by human TFF2.

Authors:  Yong Zhang; Guoyu Yu; Yanjie Wang; Yang Xiang; Qian Gao; Ping Jiang; Jie Zhang; Wenhui Lee; Yun Zhang
Journal:  Cell Mol Life Sci       Date:  2011-04-03       Impact factor: 9.261

6.  Functional expression of recombinant human trefoil factor 1 by Escherichia coli and Brevibacillus choshinensis.

Authors:  Yueh-Mei Cheng; Meng-Ting Lu; Chuan Mei Yeh
Journal:  BMC Biotechnol       Date:  2015-05-20       Impact factor: 2.563

7.  Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer.

Authors:  Yuko Ishibashi; Hiroshi Ohtsu; Masako Ikemura; Yasuko Kikuchi; Takayoshi Niwa; Kotoe Nishioka; Yoshihiro Uchida; Hirona Miura; Susumu Aikou; Toshiaki Gunji; Nobuyuki Matsuhashi; Yasukazu Ohmoto; Takeshi Sasaki; Yasuyuki Seto; Toshihisa Ogawa; Keiichiro Tada; Sachiyo Nomura
Journal:  Sci Rep       Date:  2017-07-07       Impact factor: 4.379

8.  Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies.

Authors:  Franziska Heuer; René Stürmer; Jörn Heuer; Thomas Kalinski; Antje Lemke; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

9.  The TFF Peptides xP1 and xP4 Appear in Distinctive Forms in the Xenopus laevis Gastric Mucosa: Indications for Different Protective Functions.

Authors:  René Stürmer; Jana Reising; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

10.  The trefoil factor interacting protein TFIZ1 binds the trefoil protein TFF1 preferentially in normal gastric mucosal cells but the co-expression of these proteins is deregulated in gastric cancer.

Authors:  Felicity E B May; S Michael Griffin; Bruce R Westley
Journal:  Int J Biochem Cell Biol       Date:  2008-08-03       Impact factor: 5.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.